首页 | 本学科首页   官方微博 | 高级检索  
检索        

新型冠状病毒肺炎疫情对中国成人慢性病治疗及健康状况的影响
引用本文:胡以松,王卫东.新型冠状病毒肺炎疫情对中国成人慢性病治疗及健康状况的影响[J].中华疾病控制杂志,2021,25(4):395-399.
作者姓名:胡以松  王卫东
作者单位:100872 北京,中国人民大学中国调查与数据中心
基金项目:中央高校建设世界一流大学(学科)和特色发展引导专项资金
摘    要:  目的  探讨COVID-19疫情对中国成人慢性病治疗及健康状况的影响。  方法  通过随机数字拨号方法在全国所有地市级行政单位抽取≥18岁的人群样本,通过云端电话调查系统开展问卷访问,于2020年11―12月共收集具有全国代表性的问卷5 972份。  结果  高血压患者、血脂异常患者、糖尿病/血糖升高患者中分别有2.2%、4.6%和8.8%的患者其治疗受COVID-19疫情的影响比较大或非常大。与疫情前相比,有4.2%的人群报告健康状况明显变差或有所变差。高血压患者中,自报健康状况越差,其治疗受COVID-19疫情的影响越大;血脂异常患者中,年龄越大、家庭收入低、自报健康状况越差,其血脂异常的治疗受COVID-19疫情的影响越大;中老年人、居住在城市的人群健康变差的可能性大。  结论  目前,中国高血压、血脂异常、糖尿病/血糖升高患者的治疗以及人群健康状况受疫情的影响不大,对于受影响较大的高危人群需要特别给予关注。

关 键 词:COVID-19    高血压    血脂异常    高血糖    健康状况
收稿时间:2021-02-22

The effect of COVID-19 pandemic on chronic disease treatment and health condition among Chinese adults
Institution:National Survey Research Center, Renmin University of China, Beijing 100872, China
Abstract:  Objective  To explore the effect of COVID-19 pandemic on chronic disease treatment and health condition among Chinese adults.  Methods  Random digital dialing method was used to extract respondents aged 18 years old and over from all prefectural level areas in China. A cloud-based telephone interviewing system was administered to do the questionnaire survey. A total number of 5 972 questionnaires were collected nationally from November to December 2020.  Results  The COVID-19 pandemic had some or high degree impact on hypertension treatment of 2.2% self-reported patients. In addition, 4.6% and 8.8% of patients with dyslipidemia and diabetes or high glucose were affected by COVID-19. Compared with prepandemic, a total number of 4.2% population reported a little bit or significantly worse health condition. Results showed that the treatment of hypertension was affected more by COVID-19 pandemic among patients with worse health condition. The treatment of dyslipidemia was affected more by COVID-19 pandemic among old age and low family income patients with worse health condition. Middle and old age, urban people had higher chance to getting worse heath during COVID-19 pandemic.  Conclusions  The COVID-19 pandemic has little impact on treatment of hypertension, dyslipidemia, diabetes or high glucose patients and overall health status among Chinese population at present. But special attention should paid to high risk population with chronic disease who disproportionately affected by pandemic.
Keywords:
点击此处可从《中华疾病控制杂志》浏览原始摘要信息
点击此处可从《中华疾病控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号